{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:54:54Z","timestamp":1792612494712,"version":"4.5.0"},"reference-count":30,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,5,1]]},"DOI":"10.1210\/jc.2009-2752","type":"journal-article","created":{"date-parts":[[2010,3,24]],"date-time":"2010-03-24T23:29:33Z","timestamp":1269473373000},"page":"2227-2233","source":"Crossref","is-referenced-by-count":89,"title":["Shifts in Propylthiouracil and Methimazole Prescribing Practices: Antithyroid Drug Use in the United States from 1991 to 2008"],"prefix":"10.1210","volume":"95","author":[{"given":"Ana B.","family":"Emiliano","sequence":"first","affiliation":[{"name":"Division of Endocrinology and Metabolism (A.B.E., D.S.C.), Johns Hopkins School of Medicine, Baltimore, Maryland 21287"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Governale","sequence":"additional","affiliation":[{"name":"Department of Health and Human Services (L.G., M.P.), Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Silver Spring, Maryland 20993"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Parks","sequence":"additional","affiliation":[{"name":"Department of Health and Human Services (L.G., M.P.), Public Health Service, Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Silver Spring, Maryland 20993"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism (A.B.E., D.S.C.), Johns Hopkins School of Medicine, Baltimore, Maryland 21287"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113534858000_R1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(03)14073-1","article-title":"Hyperthyroidism","volume":"362","author":"Cooper","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019041113534858000_R2","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113534858000_R3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/jcem-54-1-101","article-title":"Acute effects of propylthiouracil (PTU) on thyroidal iodide organification and peripheral iodothyronine deiodination: correlation with serum PTU levels measured by radioimmunoassay","volume":"54","author":"Cooper","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113534858000_R4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1172\/JCI107744","article-title":"Triiodothyronine and thyroxine in hyperthyroidism: comparison of the acute changes during therapy with antithyroid agents","volume":"54","author":"Abuid","year":"1974","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113534858000_R5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM198701013160104","article-title":"Induction of circulating activated suppressor-like T cells by methimazole therapy for Graves\u2019 disease","volume":"316","author":"To\u0308tterman","year":"1987","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113534858000_R6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1530\/eje.0.1510467","article-title":"Serum thyrotropin-receptor autoantibodies levels after I therapy in Graves\u2019 patients: effect of pretreatment with methimazole evaluated by a prospective, randomized study","volume":"151","author":"Andrade","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113534858000_R7","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1210\/jcem-70-6-1518","article-title":"Current trends in the management of Graves\u2019 disease","volume":"70","author":"Solomon","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113534858000_R8","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1001\/jama.1979.03300220020015","article-title":"Long-term antithyroid treatment in hyperthyroidism","volume":"242","author":"Slingerland","year":"1979","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113534858000_R9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1991.1.129","article-title":"Differences and similarities in the diagnosis and treatment of Graves\u2019 disease in Europe, Japan and the United States","volume":"1","author":"Wartofsky","year":"1991","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113534858000_R10","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves\u2019 disease","volume":"92","author":"Nakamura","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113534858000_R11","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/00007611-199509000-00018","article-title":"Single daily dose of methimazole compared to every 8 hours propylthiouracil in the treatment of hyperthyroidism","volume":"88","author":"Nicholas","year":"1995","journal-title":"South Med J"},{"key":"key\n\t\t\t\t2019041113534858000_R12","first-page":"1727","article-title":"Fifty years of experience with propylthiouracil-associated hepatotoxicity: what have we learned?","volume":"82","author":"Williams","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113534858000_R13","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMc0809750","article-title":"Ending propylthiouracil-induced liver failure in children","volume":"360","author":"Rivkees","year":"2009","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113534858000_R14","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2009-0850","article-title":"Putting propylthiouracil in perspective","volume":"94","author":"Cooper","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113534858000_R15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019041113534858000_R16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1572-0241.2001.03469.x","article-title":"The incidence and clinical characteristics of symptomatic propylthiouracil-induced hepatic injury in patients with hyperthyroidism: a single-center retrospective study","volume":"96","author":"Kim","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"key\n\t\t\t\t2019041113534858000_R17","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00019616-199911000-00008","article-title":"The side effects of antithyroid drugs","volume":"9","author":"Cooper","year":"1999","journal-title":"Endocrinologist"},{"key":"key\n\t\t\t\t2019041113534858000_R18","first-page":"121","article-title":"Adverse immunologic effects of antithyroid drugs","volume":"136","author":"Wing","year":"1987","journal-title":"CMAJ"},{"key":"key\n\t\t\t\t2019041113534858000_R19","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1210\/jc.2008-2700","article-title":"Clinical characteristics of myeloperoxidase antineutrophil cytoplasmic antibody-associated vasculitis caused by antithyroid drugs","volume":"94","author":"Noh","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 8","key":"key\n\t\t\t\t2019041113534858000_R20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1210\/jc.2007-0141","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline","volume":"92","author":"Abalovich","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113534858000_R21","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1089\/thy.2009.0169","article-title":"The role of propylthiouracil in the management of Graves\u2019 disease in adults: report of a meeting jointly sponsored by the American Thyroid Association and the Food and Drug Administration","volume":"19","author":"Bahn","year":"2009","journal-title":"Thyroid"},{"key":"key\n\t\t\t\t2019041113534858000_R22","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1210\/jcem.86.6.7573","article-title":"The use of antithyroid drugs in pregnancy and lactation","volume":"86","author":"Mandel","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113534858000_R23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/tera.1072","article-title":"Adverse effects of prenatal methimazole exposure","volume":"64","author":"Di Gianantonio","year":"2001","journal-title":"Teratology"},{"key":"key\n\t\t\t\t2019041113534858000_R24","first-page":"3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placental lobule","volume":"82","author":"Mortimer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113534858000_R25","first-page":"3633","article-title":"Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves\u2019 hyperthyroidism","volume":"82","author":"Momotani","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113534858000_R26","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1530\/EJE-07-0877","article-title":"Incidence of hyperthyroidism in Stockholm, Sweden, 2003\u20132005","volume":"158","author":"Abraham-Nordling","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t2019041113534858000_R27","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1210\/jc.2003-032089","article-title":"The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population","volume":"89","author":"Flynn","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113534858000_R28","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/archinte.165.14.1606","article-title":"Smoking and other lifestyle factors and the risk of Graves\u2019 hyperthyroidism","volume":"165","author":"Holm","year":"2005","journal-title":"Arch Intern Med"},{"key":"key\n\t\t\t\t2019041113534858000_R29","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1365-2265.2008.03338.x","article-title":"The incidence of autoimmune thyroid disease: a systematic review of the literature","volume":"69","author":"McGrogan","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t2019041113534858000_R30","first-page":"636","article-title":"Graves\u2019 disease in Olmsted County, Minnesota, 1935 through 1967","volume":"45","author":"Furszyfer","year":"1970","journal-title":"Mayo Clin Proc"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/95\/5\/2227\/9068113\/jcem2227.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T11:21:19Z","timestamp":1558956079000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/95\/5\/2227\/2596982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,1]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2009-2752","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.3778956.3507054","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.3778956.4231054","asserted-by":"object"}]},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,1]]}}}